Cardiovascular Disease Doctors in Opelousas, LA Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Dr. David John Homan, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1233 Wayne Gilmore Cir, Suite 450, Opelousas, LA 70570 Phone: 337-942-3006    Fax: 337-942-7744

Dr. Usman Alam, M.D., Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 E Prudhomme St, Suite 3, Opelousas, LA 70570 Phone: 337-942-5750    Fax: 337-948-9405

Kalyan Kumar Veerina, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1233 Wayne Gilmore Circle, Suite 450, Opelousas, LA 70570 Phone: 337-942-3006    Fax: 337-942-7744

Dr. Siby George Ayalloore, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1233 Wayne Gilmore Cir Ste 450, Opelousas, LA 70570 Phone: 337-942-3006    Fax: 337-942-7744

News Archive

Moved overseas for school, stayed for insulin

Every now and then, Katie West considers returning to the United States. She moved to Germany for graduate school three years ago and now works as a health systems researcher in Hamburg. Her family is an ocean away. Then she remembers why she stays.

The neurobiology of music perception and production related to the pathways affecting intrinsic attachment behavior?

Music is social communication between individuals - humming of lullabies attach infant to parent and singing or playing music adds croup cohesion. The neurobiology of music perception and production is likely to be related to the pathways affecting intrinsic attachment behavior, suggests a resent Finnish study. The study gives new information about genetic background of musical aptitude.

New use of green fluorescent protein

Scientists are reporting discovery of a way to help proteins such as the new generation of protein-based drugs - sometimes heralded as tomorrow's potential "miracle cures" - get past the biochemical "Entrance Forbidden" barrier that keeps them from entering cells and doing their work. The new technique, described in the monthly journal, ACS Chemical Biology, represents a new use for an engineered form of green fluorescent protein, the topic of the 2008 Nobel Prize in Chemistry that is one of the most important research tools in biosciences.

Two studies investigate role of oxygen in cell transplantation

Two studies published in the current issue of Cell Transplantation, now freely available on-line, investigate the role of oxygen in cell transplantation.

Ranbaxy receives tentative approval to manufacture Valganciclovir hydrochloride tablets

Ranbaxy Laboratories Limited (RLL), announced today that the company has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Valganciclovir Hydrochloride Tablets, 450 mg. Total annual market sales for Valganciclovir HCl Tablets were $239 million (IMS - MAT: March 2008).

Read more Medical News

› Verified 7 days ago